GILD

Gilead Sciences, Inc. News Headlines

$103.83
*  
0.30
0.29%
Get GILD Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Why I Expect The Biotech Sell-Off To Continue Into 2015
12/24/2014 8:08:00 AM - Seeking Alpha


Gilead Feels The Heat Of Competition
12/24/2014 7:59:00 AM - Seeking Alpha


4 Reasons I'm Adding Gilead To My Healthcare Holdings
12/24/2014 7:18:00 AM - Seeking Alpha


Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
12/24/2014 5:37:00 AM - Seeking Alpha


AQR Capital Management’s 3Q14 positions
12/23/2014 9:59:00 PM - Market Realist


AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
12/23/2014 4:41:00 PM - Seeking Alpha


Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
12/23/2014 12:02:00 PM - Investopedia


Stock Market News for December 23, 2014 - Market News
12/23/2014 10:10:00 AM - Investopedia


Enanta Is The Big Winner In The Hepatitis C War Between AbbVie And Gilead
12/23/2014 8:47:00 AM - Seeking Alpha


AbbVie Competes On Price
12/23/2014 7:58:00 AM - Seeking Alpha


Gilead Sciences: Buy On The Drop?
12/23/2014 7:35:00 AM - Seeking Alpha


Cramer's Mad Money - Is Competition Killing Gilead? (12/22/14)
12/23/2014 5:50:00 AM - Seeking Alpha


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 AM - Investopedia


Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
12/23/2014 4:50:00 AM - Investopedia


Making Money With Charles Payne: 12/22/14
12/22/2014 6:00:00 PM - Fox Business


Commentary On Gilead Sciences' Recent Plunge
12/22/2014 5:15:00 PM - Seeking Alpha


Why I Am Not Selling Gilead
12/22/2014 3:37:00 PM - Seeking Alpha


A Victory For Express Scripts And AbbVie At The Expense Of Gilead Sciences, J&J And... Oh Yeah, Patients
12/22/2014 2:36:00 PM - Seeking Alpha


AbbVie Versus Gilead In Hepatitis C, With Comments On Biotech
12/22/2014 2:09:00 PM - Seeking Alpha


Stocks Turning In A Lackluster Performance In Mid-Day Trading - U.S. Commentary
12/22/2014 12:08:00 PM - RTT News


Today's Market: Hepatitis C News Moving These Stocks
12/22/2014 10:39:00 AM - Seeking Alpha


Stocks Move Modestly Higher, Extending Upward Trend - U.S. Commentary
12/22/2014 10:33:00 AM - RTT News


Gilead Sciences Inc. (GILD) Is Sinking After Express Scripts Announcement
12/22/2014 9:43:00 AM - RTT News


Year-End Portfolio Review And My 5 Best Ideas For 2015
12/22/2014 9:20:00 AM - Seeking Alpha


Express Scripts To Cover AbbVie's Newly Approved Hepatitis C Drug
12/22/2014 8:28:00 AM - RTT News